Page 151 - 22-0722 EBOOK
P. 151
วารสารราชบััณฑิิตยสภา
ปีีที่่� ๔๖ ฉบัับัที่่� ๓ กัันยายน-ธัันวาคม ๒๕๖๔
ศาสตราจารย์์ ดร.เกศินีี โชติวานีิช และคณะ 141
Rason, M. A., Randriantsoa, T., Andrianantenaina, H., Ratsimbasoa, A., Menard, D. (2008).
Performance and reliability of the SYBR Green I based assay for the routine
monitoring of susceptibility of Plasmodium falciparum clinical isolates.
Trans R Soc Trop Med Hyg. 102: 346−351.
Rieckmann, K. H., Campbell, G. H., Sax, L. J., Mrema, J. E. (1978). Drug sensitivity of
Plasmodium falciparum. An in-vitro microtechnique. Lancet. 1: 22−23.
Smilkstein, M., Sriwilaijaroen, N., Kelly, J. X., Wilairat, P., Riscoe, M. (2004). Simple and
inexpensive fluorescence-based technique for highthroughput antimalarial
drug screening. Antimicrob Agents Chemother. 48: 1803−1806.
Udomsangpetch, R., Kaneko, O., Chotivanich, K., Sattabongkot, J. (2008). Cultivation of
Plasmodium vivax. Trends Parasitol. 24(2): 85−88.
Vachot-Ganée, L., Khim, N., Iannello, A., Legrand, E., Kim, S., Eam, R., Khean, C., Ken,
M., Ashley, E., Tun, K. M., Dhorda, M., Nosten, F., Souleymane, I. M., Blein,
S., Pachot, A., Ariey, F., Kaiser, K., Ménard, D. (2018). A novel field-based
molecular assay to detect validated artemisinin-resistant k13 mutants.
Malar J. 24; 17(1): 175−178.
Vossen, M. G., Pferschy, S., Chiba, P., Noedl, H. (2010). The SYBR Green I malaria drug
sensitivity assay: performance in low parasitemia samples. Am J Trop Med
Hyg. 82(3): 398−401.
Wein, S., Maynadier, M., Tran Van Ba, C., Cerdan, R., Peyrottes, S., Fraisse, L. (2010).
Reliability of antimalarial sensitivity tests depends on drug mechanisms of
action. J Clin Microbiol. 48: 1651−1660.
Witkowski, B., Amaratunga, C., Khim, N., Sreng, S., Chim, P., Kim, S., Lim, P., Mao, K.,
Sopha, S., Sam, B., Anderson, J. M., Duong, S., Chuor, C. M., Taylor, W., Suon, S.,
Mercereau-Puijalon, O., Fairhurst, R. M., Menard, M. (2013). Novel phenotypic
assays for the detection of artemisinin-resistant Plasmodium falciparum
malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet
Infect Dis. 13(12): 1043–1049.
